Chì significà "Clear"?
L'animali ùn porta micca a mutazione. Ùn svilupperà micca a malatia è ùn la trasmetterà.
Cane Sindrome Myasthenic Congenital In Heideterrier (CMS-H)
Discover the importance of the DNA test for Congenital Myasthenic Syndrome (CMS) in Heideterriers, a hereditary neuromuscular disorder affecting this unique dog breed. Early genetic screening helps breeders identify carriers and prevent the transmission of CMS, ensuring healthier litters. This precise DNA test detects mutations linked to CMS, allowing for informed breeding decisions and improved canine health. Regular testing supports responsible breeding practices and enhances the overall well-being of Heideterriers. Protect your dog’s future by choosing reliable CMS DNA testing today. Stay proactive in managing congenital health risks with advanced genetic tools.
Abbreviazione: CMS-H
mutazione analizzata: CHRNE c.1436_1437insG
Eredità : Autosomal Recessive
Acronimu
CMS-H
Frequenza osservata
Gravità clinica
Classificazione clinica
Malatie Neuromuscular
Mutazione analizata
CHRNE c.1436_1437insG
p.(S503Rfs*14)
p.(S503Rfs*14)
Modu di l'eredi
Autosomal Recessive
Riassuntu di a prova:
The DNA test for Congenital Myasthenic Syndrome (CMS) in Heideterriers helps identify genetic mutations responsible for this inherited neuromuscular disorder. CMS causes muscle weakness and fatigue due to impaired nerve-to-muscle communication. Early detection through genetic testing enables breeders to make informed decisions and reduce the risk of passing the condition to offspring. This test is essential for maintaining the health and vitality of the Heideterrier breed. Regular screening supports responsible breeding and improves overall canine welfare.
Disponibile da u pacchettu: Basic
Questa prova di DNA hè inclusa partendu da u nostru pacchettu Basic — è hè ancu parte di i pacchetti Basic, Standard, Advanced, Complete.
Vede i pacchetti di test di DNA →Sceglite u pacchettu chì si adatta megliu à a vostra strategia di allevamentu o di salute di i vostri animali.
Overview of Congenital Myasthenic Syndrome (CMS)
Congenital Myasthenic Syndrome (CMS) is a group of inherited neuromuscular disorders characterized by weakness and fatigue of voluntary muscles. This condition results from defects in the transmission of nerve impulses to muscles, leading to compromised muscle function. It is caused by genetic mutations that affect the proteins responsible for neuromuscular transmission, notably at the neuromuscular junction where nerve cells communicate with muscles.
Symptoms of CMS in Dogs
Dogs affected by CMS may exhibit a range of symptoms, including muscle weakness, exercise intolerance, and fatigue. Some dogs may also show signs of difficulty in swallowing, facial muscle weakness, and a tendency to collapse after exertion. These symptoms can vary in severity and may be mistaken for other conditions, making a proper diagnosis crucial for effective management.
Importance of DNA Testing for CMS
DNA testing plays a vital role in identifying genetic mutations associated with Congenital Myasthenic Syndrome. By analyzing specific genes known to be linked to CMS, veterinarians and breeders can better understand the genetic predisposition of individual dogs. This information is crucial for making informed breeding decisions and helps in managing the condition in affected dogs.
Opzioni di gestione è trattamentu
Currently, there is no cure for Congenital Myasthenic Syndrome; however, management strategies are available to improve the quality of life for affected dogs. Treatment often includes the use of medications such as anticholinesterase agents, which can enhance neuromuscular transmission. Supportive care, including physical therapy and nutritional management, is also essential to help maintain muscle function and overall health.
Cunclusioni
Congenital Myasthenic Syndrome is a serious condition that can significantly affect the life of a dog. Early diagnosis through DNA testing can facilitate proper management and care, ensuring that affected dogs receive the support they need to lead a fulfilling life. Understanding the implications of this condition is vital for dog owners, breeders, and veterinary professionals alike.
Razza ricunnisciuta per a prova : Sindrome Myasthenic Congenital In Heideterrier (CMS-H)
- Heideterrier
- Smooth Fox Terrier
🧬 Interpretation of genotypes CMS-H
Genotipu
Status
🟡 N/N
Non trasportatore - Nisun Riscu
🟡 N/CMS-H
Carrier - Nisun Riscu
❌ CMS-H/CMS-H
Affettatu - À Risicu
FAQ: capiscenu l'interpretazione
Hè un "Carrier" seriu?
No. L'animali hè generalmente sanu, ma pò trasmette a mutazione à u so prole.
E se un animale hè "Affettatu"?
Porta duie copie mutate. I segni clinichi sò previsti secondu a malatia. Ùn deve esse criatu.
Perchè ci sò differenze trà maschile / femina?
Alcune malatie sò ligati à u sessu, cusì a so espressione varieghja secondu u sessu di l'animali.
Prevede a prole
N/N (non-traspurtadore)
N/CMS-H (Carrier)
CMS-H/CMS-H (Affettatu)
FAQ Test di DNA
Chì rileva stu test di DNA?
This DNA test detects the mutation associated with Congenital Myasthenic Syndrome In Heideterrier (CMS-H) in order to identify clear, carrier, or at-risk animals.
Perchè pruvà un animale di ripruduzzione?
A prova di DNA aiuta i criatori à pianificà accoppiamenti più sicuri è riduce u risicu di trasmette a mutazione à a prole.
Chì ghjè u modu di eredità di sta prova?
U modu di eredità rappurtatu per questa prova hè Autosomal Recessive.
Quale mutazione hè analizata in questa prova?
This test analyses the mutation CHRNE c.1436_1437insG.
Hè un animale trasportatore necessariamente affettatu?
Micca necessariamente. L'interpretazione dipende da u mudellu di eredità è u genotipu resultanti.
Referenze
Herder Vanessa, Ciurkiewicz Malgorzata, Baumgärtner Wolfgang, Jagannathan Vidhya, Leeb Tosso. Frame-shift variant in the CHRNE gene in a juvenile dog with suspected myasthenia gravis-like disease. Anim Genet. 2017 Oct;48(5):625. doi: 10.1111/age.12558. Epub 2017 May 16.